334 related articles for article (PubMed ID: 34827413)
1. Update on Paraneoplastic Cerebellar Degeneration.
Loehrer PA; Zieger L; Simon OJ
Brain Sci; 2021 Oct; 11(11):. PubMed ID: 34827413
[No Abstract] [Full Text] [Related]
2. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
[TBL] [Abstract][Full Text] [Related]
3. Rhombencephalitis associated with isolated Zic4-antibodies in Paraneoplastic cerebellar degeneration: a case report.
Loehrer PA; Timmermann L; Pehl A; Bien CI; Pfestroff A; Pedrosa DJ
BMC Neurol; 2020 May; 20(1):208. PubMed ID: 32450842
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic cerebellar degeneration associated with anti-Yo antibodies in an ovarian cancer case: A case report.
Deac S; Stana MM; Havasi AD; Cainap C; Popita AR; Bordeianu AM; Cainap S; Bota M; Bochis OV
Gynecol Oncol Rep; 2021 Feb; 35():100695. PubMed ID: 33490355
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report.
Kumari VA; Gupta P; Srivastava MV; Kumar L; Kriplani A; Bhatla N
J Obstet Gynaecol Res; 2014 May; 40(5):1463-5. PubMed ID: 24689522
[TBL] [Abstract][Full Text] [Related]
6. Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration: Case Series and Review of Literature.
Chatham M; Niravath P
Cureus; 2021 Dec; 13(12):e20203. PubMed ID: 35004023
[TBL] [Abstract][Full Text] [Related]
7. An Etiological Investigation of Paraneoplastic Cerebellar Degeneration in Ovarian Cancer Patients: A Systematic Review.
Fidahussain AA; Abid A; Paracha AA; Jeevan VE; Rueve J; Engelhardt M; Schrock C; Ghani S; Nair HK
Cureus; 2022 Nov; 14(11):e31154. PubMed ID: 36483902
[TBL] [Abstract][Full Text] [Related]
8. A cerebellar degeneration-related protein 2-like cell-based assay for anti-Yo detection in patients with paraneoplastic cerebellar degeneration.
Erikstad KI; Herdlevaer I; Peter E; Haugen M; Totland C; Vedeler C
Eur J Neurol; 2023 Jun; 30(6):1727-1733. PubMed ID: 36912432
[TBL] [Abstract][Full Text] [Related]
9. Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report.
Pozas J; Albarrán-Fernández V; González-Campo L; Olmedo-García ME; Corral de la Fuente E; Corral-Corral I; Carrasco Á; Alonso-Gordoa T; Molina-Cerrillo J; Lage-Alfranca Y; Gómez-Rueda A; Garrido P
Transl Lung Cancer Res; 2022 Jul; 11(7):1497-1502. PubMed ID: 35958343
[TBL] [Abstract][Full Text] [Related]
10. Anti-Tr/DNER antibody paraneoplastic cerebellar degeneration preceding a very late relapse of Hodgkin Lymphoma after 12 years.
Christensen PB; Gregersen H; Almasi C
Cerebellum Ataxias; 2021 Jun; 8(1):14. PubMed ID: 34090521
[TBL] [Abstract][Full Text] [Related]
11. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review.
Le May M; Dent S
Curr Oncol; 2018 Dec; 25(6):e585-e591. PubMed ID: 30607127
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic cerebellar and brainstem disorders.
Abbatemarco JR; Vedeler CA; Greenlee JE
Handb Clin Neurol; 2024; 200():173-191. PubMed ID: 38494276
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
Lehner MJ; Gheeya JS; Siddiqui BA; Tummala S
J Neurooncol; 2021 Jul; 153(3):441-446. PubMed ID: 34076832
[TBL] [Abstract][Full Text] [Related]
14. Combined Cerebellar and Spinal Cord Deficits Caused by an Underlying Gynecologic Malignancy.
Othman T; Hendizadeh MS; Vankina R; Park S; Kim P
Case Rep Oncol Med; 2020; 2020():9021843. PubMed ID: 31970005
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.
Panja D; Vedeler CA; Schubert M
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):141-156. PubMed ID: 29679372
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer and paraneoplastic cerebellar degeneration.
Waterhouse DM; Natale RB; Cody RL
Cancer; 1991 Oct; 68(8):1835-41. PubMed ID: 1913530
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic Cerebellar Degeneration: The Importance of Including CDR2L as a Diagnostic Marker.
Herdlevær I; Haugen M; Mazengia K; Totland C; Vedeler C
Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33531379
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic cerebellar degeneration associated with an onconeural antibody against creatine kinase, brain-type.
Tetsuka S; Tominaga K; Ohta E; Kuroiwa K; Sakashita E; Kasashima K; Hamamoto T; Namekawa M; Morita M; Natsui S; Morita T; Tanaka K; Takiyama Y; Nakano I; Endo H
J Neurol Sci; 2013 Dec; 335(1-2):48-57. PubMed ID: 24018129
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma.
Valpione S; Zoccarato M; Parrozzani R; Pigozzo J; Giometto B; Laveder F; Aliberti C; Chiarion-Sileni V
J Neurol Sci; 2013 Dec; 335(1-2):210-2. PubMed ID: 24035275
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.
Small M; Treilleux I; Couillault C; Pissaloux D; Picard G; Paindavoine S; Attignon V; Wang Q; Rogemond V; Lay S; Ray-Coquard I; Pfisterer J; Joly F; Du Bois A; Psimaras D; Bendriss-Vermare N; Caux C; Dubois B; Honnorat J; Desestret V
Acta Neuropathol; 2018 Apr; 135(4):569-579. PubMed ID: 29299667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
